Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Shandong Keyuan Pharmaceutical Co Ltd
Other Items
Shandong Keyuan Pharmaceutical Co Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
|
Other Items
¥108.8m
|
CAGR 3-Years
621%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Items
-¥5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Items
¥594.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Items
-¥1.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
21%
|
CAGR 10-Years
0%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Other Items
-¥2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Items
-¥2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shandong Keyuan Pharmaceutical Co Ltd
Glance View
Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.
See Also
What is Shandong Keyuan Pharmaceutical Co Ltd's Other Items?
Other Items
108.8m
CNY
Based on the financial report for Dec 31, 2024, Shandong Keyuan Pharmaceutical Co Ltd's Other Items amounts to 108.8m CNY.
What is Shandong Keyuan Pharmaceutical Co Ltd's Other Items growth rate?
Other Items CAGR 3Y
621%
The average annual Other Items growth rates for Shandong Keyuan Pharmaceutical Co Ltd have been 621% over the past three years .
